A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE)

NCT06783192 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus (HIV)
HIV Pre-Exposure Prophylaxis

Interventions

DRUG: MK-8527
DRUG: LNG/EE

Sponsor

Merck Sharp & Dohme LLC